58754-49-7

Upstream product

• 50-00-0 formaldehyd 
• 87085-10-7 N-Desmethylencainide 
• 7730-87-2 1-methylpiperidine-2-carboxylic acid 
• 100-07-2 4-methoxy-benzoyl chloride 
• 37611-80-6 2-(ortho-aminophenethyl)-1-methylpiperidine 
• 153707-63-2 4-methoxy-N-<2-<1-hydroxy-2-(2-pyridinyl)ethyl>phenyl>benzamide 
• 87165-92-2 4-methoxy-N-<2-(2-pyridinylacetyl)phenyl>benzamide 
• 37619-28-6 methyl 2-[(4-methoxybenzoyl)amino]benzoate 
• 109-06-8 α-picoline 
• 153707-65-4 N-{2-[1-Hydroxy-2-(1-methyl-1,2,5,6-tetrahydro-pyridin-2-yl)-ethyl]-phenyl}-4-methoxy-benzamide 

Downstream Products

• 58754-42-0 2-[2-[(p-methoxybenzyl)amino]phenethyl]-1-methylpiperidine 

Relevant academic research and scientific papers

Decarboxylative Anti-Michael Addition to Olefins Mediated by Photoredox Catalysis

Decarboxylative coupling of carboxylic acids with activated olefins has been accomplished using visible light photoredox catalysis. The strategic placement of a radical-stabilizing aromatic group at the β-position of the olefin component biases the regios

Substituted piperidines

The compounds are of the heterocyclic class of 2-phenethylpiperidines having an amido substituent in the ortho position of the phenethyl moiety. Substituents in the ortho position include formamido, benzamido, cinnamamido, 2-thiophenecarboxamido, alkanesulfonamido and alkanoylamido. They are useful as antiarrhythmic and/or antiserotonin agents. The novel compounds are prepared by reaction of appropriately substituted o-aminophenethylpiperidines and the carbonyl or sulfonyl halides or anhydrides. Typical embodiments of this invention are 4-methoxy-2'-[2-(1-methyl-2-piperidyl)ethyl]benzanilide and 2'-[2-(1-methyl-2-piperidyl)ethyl]cinnamanilide.